Health-Enhancing Adapted Physical Activity Program at "Mon Stade"
Condition(s) studied
Investigational drug(s) / intervention(s)
Adapted Physical Activity: A 16-week health-adapted physical activity program, individualized from baseline evaluation of participants including the specificities of their pathologies
Study summary
Introduction: Regular practice of exercise or physical activity (PA) is a recognized intervention as a determinant of good health acquisition, maintenance, or recovery for a large number of chronic pathologies. Nevertheless, few studies have evaluated adherence to an initial health-adapted PA (APA) program, and persistence of active behavior over the time in individuals with a chronic disease.
The aim of the study is to determine the brakes and levers associated with motivation and long-term compliance. In addition, the investigators aim to evaluate the cost-effectiveness of such program in term of care consumption. Finally, the investigators complete their interest for APA prescription from practitioners agreeing to enroll their patients in the present study.
Method: The investigators perform a prospective monocentric cohort, of 2024 patients affected of a chronic disease or long-term illness (LTI), enrolled from 2021 to 2024 (4 years, 506 per year), for a 16-week APA program, and followed 5 years with an annual fitness and habits of life and care consumption evaluation.
Eligibility
Primary outcome measure(s)
- 5-year persistence of a positive trajectory of active behavior — 5 years
Study of the brakes and levers associated with the persistence at 5 years of an initial 16-week APA program, of a positive trajectory of the percentages of "moderate to vigorous" AP practice collected by wearing for 7 days a wGT3X-BT type accelerometer (Actigraph, Pensacola, FL, USA), illustrating the persistence of the favorable change in behavior eventually induced
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Mon Stade Sports Medicine Center | Paris | France | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04716322 on ClinicalTrials.gov ↗ ← All trials in France